11月18日，减重版司美格鲁肽（商品名：诺和盈，Wegovy）在上海复旦大学附属医院开出全国首批处方。全球首个用于长期体重管理的胰高糖素样肽-1受体激动剂（GLP-1）周制剂在国内获批近5个月后，终于迎来商业化。 官方定价尚未公布，预约价格开始上涨 ...

James McMaster, the company’s chief executive, said this had helped it appeal to a wider swathe of health-conscious consumers and that the rise of Ozempic ... known as GLP-1 agonists, work ...

And what we know is, that doesn’t work.” Dr. Daniel Drucker, a pioneer of research into GLP-1, the hormone Ozempic and similar drugs mimic, agreed. “I don’t think anyone who is in the ...

In the race to find Ozempic 2.0, a few stand-outs are emerging. While GLP-1 drugs have paved the way for a new era of healthcare, they have some drawbacks. They need to be injected (a draw-back ...

GLP-1 medications are breakthroughs for weight loss, diabetes, and more. Pharma companies are clamoring to produce pills or longer-lasting drugs with faster effects. Novo Nordisk, Eli Lilly, Viking ...

These weight-loss drugs support weight loss by mimicking the hormone GLP-1, which helps regulate appetite and satiety. Semaglutide is sold under the brand name Ozempic when it’s prescribed for ...